Mandana Khalili, MD

Mandana Khalili, MD, is Chief of Clinical Hepatology and Director of Clinical and Translational Research in Hepatology at San Francisco General Hospital, and directs the UCSF T32 Hepatology Training Program.

Articles by Mandana Khalili, MD

The Liver Keeps the Score: Americans Are Drinking Less, but Alcohol-Associated Liver Disease May Lag

ByMandana Khalili, MD,Stevan Gonzalez, MD, MS,Brian Lee, MD,Frances Lee, MD

October 2nd 2026

Drinking fell for the first time since COVID-19, but not for adults 50 to 64. Hepatologists explain what clinicians can do to close the gap.

Baseline Motivation Predicts Alcohol Reduction in Chronic Liver Disease

ByMandana Khalili, MD

August 6th 2026

Mandana Khalili, MD, discusses how baseline motivation predicted alcohol reduction in a stepped treatment trial for liver disease patients.

Telehealth Stepped Alcohol Care Reduced Drinking in Liver Disease

ByMandana Khalili, MD

July 24th 2026

Telehealth stepped alcohol treatment reduced weekly drinking, but not the primary endpoint, among patients with chronic liver disease.

Mandana Khalili, MD

Articles by Mandana Khalili, MD

The Liver Keeps the Score: Americans Are Drinking Less, but Alcohol-Associated Liver Disease May Lag

Baseline Motivation Predicts Alcohol Reduction in Chronic Liver Disease

Telehealth Stepped Alcohol Care Reduced Drinking in Liver Disease

Latest Updated Articles

Trending on HCPLive

Tozorakimab Improves Daily Respiratory Symptoms in COPD: OBERON, TITANIA

Retatrutide Lowers Albuminuria, Glomerular Pressure in Obesity and CKD

Kidney Compass: ORIGIN 3 Final eGFR Data for Atacicept in IgA Nephropathy

Sibeprenlimab Stabilizes eGFR Over 24 Months in IgA Nephropathy: VISIONARY

Depemokimab Year 1 Remission Linked to Better Year 2 Asthma Outcomes